3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
6
Gastrointestinal
3
Dermatologic
3
Breast
3
Thoracic
2
Other
2
CNS
2
Sarcoma
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Conditions
Head and Neck Neoplasms
686
Squamous Cell Carcinoma of Head and Neck
203
Thyroid Neoplasms
182
Mouth Neoplasms
127
Oropharyngeal Neoplasms
89
Thyroid Nodule
88
Breast Neoplasms
73
Neoplasms
71
Nasopharyngeal Carcinoma
69
Laryngeal Neoplasms
65
Lung Neoplasms
61
Thyroid Cancer, Papillary
42
Prostatic Neoplasms
41
Carcinoma, Squamous Cell
40
Nasopharyngeal Neoplasms
35
Esophageal Neoplasms
35
Deglutition Disorders
33
Stomatitis
32
Thyroid Diseases
31
Colorectal Neoplasms
30
Xerostomia
29
Hypopharyngeal Neoplasms
29
Uterine Cervical Neoplasms
28
Melanoma
25
Carcinoma, Non-Small-Cell Lung
24
Motor Activity
23
Tongue Neoplasms
22
Sarcoma
22
Pancreatic Neoplasms
22
Colonic Neoplasms
22
Interventions
erythromycin propionate-N-acetylcysteinate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Death
×
Head & Neck
×
Clear all
NCT02966509
2018-10-31
EPAC
Stanford University
Phase NA
Completed
213 enrolled
20 charts